Genesis Fertility Centre



Genesis Fertility Centre

January 29, 2014 14:00 ET

Vancouver's Genesis Fertility Clinic is First in Canada to Offer Groundbreaking Early Embryo Viability Assessment (EEVA™) Test

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Jan. 29, 2014) - Genesis Fertility Centre, an in vitro fertilization (IVF) clinic in Vancouver, today announces it is the first clinic in Canada, and the first commercial clinic in North America, to offer patients the Early Embryo Viability Assessment (Eeva) Test developed by Auxogyn Inc., a company dedicated to advancing women's reproductive health by turning scientific discoveries into clinical validated solutions. The Eeva Test delivers objective, automated and actionable information regarding embryo development potential that IVF clinicians and patients can use to make important treatment decisions.

"We are proud to be the first clinic in Canada and the first commercial clinic in North America to offer the Eeva Test, continuing our legacy of dedication to providing patients with the newest cutting-edge technology and the highest possible quality of care," says Dr. Sonya Kashyap MD, medical director at Genesis Fertility. "Our patients' overall experience and successful IVF outcomes are two of our most important goals, and Eeva helps us to achieve both. In fact, we already have two couples who are pregnant using the Eeva Test."

"The commercial availability of the Eeva Test in North America marks a major milestone in the continued adoption of Eeva in leading fertility centres around the world," says Lissa Goldenstein, president and chief executive officer of Auxogyn. "Dr. Kashyap and the team at Genesis Fertility have established a first-class clinic that has the characteristics we seek in our partners and we expect that offering Eeva will help them optimize the treatment path for their patients who are undergoing IVF procedures."

Appointments for the new test are available from Genesis Fertility by calling 604-879-3032 or visiting genesis-fertility.com.

About Genesis Fertility Centre

Genesis Fertility Centre is a British Columbian fertility clinic that was established in 1995. Since its inception, the clinic has helped couples and individuals conceive using advanced reproductive technology as well as individualized, patient-centric holistic care and treatment plans. Now under new leadership, the Centre has become the first Canadian fertility clinic to voluntarily undergo independent verification of success rates by IVF Reports and Fertility authority, recognized leaders in IVF standards and patient advocacy. The centre is also the first in the province to achieve pregnancy using technologically advanced procedures including testicular sperm extraction (TESE) and micro epididymal sperm aspiration (MESA). For more information, please visit www.genesis-fertility.com or follow us on Twitter @GenesisIVFBC.

About Auxogyn

Auxogyn is a leader in reproductive health that provides novel scientific and clinically validated solutions to IVF clinicians and their patients by translating scientific discoveries in early embryo development into clinical tools. The Company's flagship product, the Eeva™ Test, delivers objective information regarding embryo development that IVF clinicians and patients can use to make important treatment decisions. Auxogyn is privately held and funded by Kleiner Perkins Caufield & Byers, Merck Serono Ventures, SR One and TPG Biotech. For more information visit auxogyn.com and follow us on Twitter @Auxogyn.

About the Eeva™ Test

The Eeva Test provides IVF clinicians with information about the embryo's development potential. Eeva proprietary software automatically analyzes embryo development against scientifically validated cell-division parameters conceived by researchers at Stanford University in the US. With results from the Eeva Test, IVF teams will have morphological assessment and objective information to aid their embryo selection decisions. The Eeva Test was evaluated in a prospective, multi-center, 160-patient prospective multi-center trial with ~1,800 embryos. Results of this study were presented in July 2012 at the European Society of Human Reproduction and Embryology (ESHRE) Annual Meeting and published by Conaghan et al in Fertility and Sterility, August 2013 [Print Edition].

The Eeva Test is currently CE Marked and available for use in the EU and licensed for sale in Canada. The FDA submission is pending and Eeva is not available for sale in the United States. For a full list of clinics offering the Eeva Test please visit www.eevaivf.com.

Contact Information